Last updated: 18 July 2019 at 5:05pm EST

Partners L P/Ilbiotechnolog... Net Worth




The estimated Net Worth of Partners L P/Ilbiotechnolog... is at least $33.5 Million dollars as of 3 December 2013. Partners Ilbiotechnolog owns over 189,800 units of Rigel Pharmaceuticals stock worth over $16,237,325 and over the last 12 years Partners sold RIGL stock worth over $17,255,926.

Partners Ilbiotechnolog RIGL stock SEC Form 4 insiders trading

Partners has made over 10 trades of the Rigel Pharmaceuticals stock since 2012, according to the Form 4 filled with the SEC. Most recently Partners bought 189,800 units of RIGL stock worth $950,898 on 3 December 2013.

The largest trade Partners's ever made was buying 1,289,354 units of Rigel Pharmaceuticals stock on 8 October 2013 worth over $6,885,150. On average, Partners trades about 328,564 units every 36 days since 2012. As of 3 December 2013 Partners still owns at least 1,251,914 units of Rigel Pharmaceuticals stock.

You can see the complete history of Partners Ilbiotechnolog stock trades at the bottom of the page.



Insiders trading at Rigel Pharmaceuticals

Over the last 21 years, insiders at Rigel Pharmaceuticals have traded over $170,041,384 worth of Rigel Pharmaceuticals stock and bought 2,068,700 units worth $7,281,949 . The most active insiders traders include Partners L P/Ilbiotechnolog..., Ansbert Gadicke, and Partners L P/Ilbiotechnolog.... On average, Rigel Pharmaceuticals executives and independent directors trade stock every 46 days with the average trade being worth of $961,207. The most recent stock trade was executed by David A Santos on 2 February 2024, trading 14,519 units of RIGL stock currently worth $16,552.



What does Rigel Pharmaceuticals do?

rigel pharmaceuticals, inc., is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases.



What does Rigel Pharmaceuticals's logo look like?

Rigel Pharmaceuticals logo

Complete history of Partners Ilbiotechnolog stock trades at ChemoCentryx Inc, Ligand Pharmaceuticals, and Rigel Pharmaceuticals

Date
#
Company
Insider
Trans.
Transaction
Shares Price per share Total value Shares after Source
3 Dec 2013 Partners L P/Ilbiotechnolog...
Buy 189,800 $5.01 $950,898
3 Dec 2013
1,251,914
4 Nov 2013 Partners L P/Ilbiotechnolog...
Buy 136,066 $4.92 $669,445
4 Nov 2013
1,194,288
30 Oct 2013 Partners L P/Ilbiotechnolog...
Buy 336,225 $4.99 $1,677,763
30 Oct 2013
1,105,733
8 Oct 2013 Partners L P/Ilbiotechnolog...
Buy 1,289,354 $5.34 $6,885,150
8 Oct 2013
985,656
3 Oct 2013 Partners L P/Ilbiotechnolog...
Buy 109,425 $5.49 $600,743
3 Oct 2013
524,011
11 Sep 2013 Partners L P/Ilbiotechnolog...
Buy 325,635 $5.95 $1,937,528
11 Sep 2013
485,412
19 Nov 2013 Partners L P/Ilbiotechnolog...
Sale 484,622 $2.64 $1,279,402
19 Nov 2013
646,559
23 Sep 2013 Partners L P/Ilbiotechnolog...
Sale 359,023 $44.50 $15,976,524
23 Sep 2013
296,345
14 Dec 2012 Partners L P/Ilbiotechnolog...
Buy 5,386 $18.63 $100,341
14 Dec 2012
2,123,812
6 Dec 2012 Partners L P/Ilbiotechnolog...
Buy 50,100 $17.94 $898,794
6 Dec 2012
2,118,426


Rigel Pharmaceuticals executives and stock owners

Rigel Pharmaceuticals executives and other stock owners filed with the SEC include: